Absence of the CAAX endoprotease Rce1: Effects on cell growth and transformation

Molecular and Cellular Biology

Volumn 22, Issue 1, 2002, Pages 171-181

  Bergo, M O ^a   Ambroziak, P ^a   Gregory, C ^a   George, A ^a   Otto, J C ^a   Kim, E ^a   Nagase, H ^a   Casey, P J ^a   Balmain, A ^a   Young, S G ^a  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAAX PROTEIN; CYSTEINE; HYBRID PROTEIN; METHYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN ICMT; PROTEIN RCE1; PROTEINASE; RAS PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; ISOPRENYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN MODIFICATION;

ALKYL AND ARYL TRANSFERASES; ALLELES; AMINO ACID MOTIFS; ANIMALS; CELL DIVISION; CELL FRACTIONATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; ENDOPEPTIDASES; FARNESYLTRANSTRANSFERASE; FIBROBLASTS; GENE TARGETING; GENES, RAS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAS PROTEINS; SKIN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036132907     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.1.171-181.2002     Document Type: Article

References (40)

1. Ras and a-factor converting enzyme
2. Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells
3. Modulation of Ras and a-factor function by carboxyl-terminal proteolysis
4. Protein prenylation
5. Detection of dibenzol/a,l/pyrene-induced H-ras codon 61 mutant genes in preneoplastic SENCAR mouse skin using a new PCR-RFLP method
6. ras farnesyltransferase, the counterpart of yeast DPR1/RAM1
7. High level expression of mammalian protein farnesyltransferase in a baculovirus system. The purified protein contains zinc
8. Inhibition of K-ras-transformed rodent and human cancer cell growth via induction of apoptosis by irreversible inhibitors of Ras endoprotease
9. The C-terminal polylysine region and methylation of K-Ras are critical for the interaction between K-Ras and microtubules
10. Endomembrane trafficking of Ras: The CAAX motif targets proteins to the ER and Golgi
11. Posttranslational modification of the Ha-ras oncogene protein: Evidence for a third class of protein carboxyl methyltransferases
12. Farnesyltransferase inhibitors and cancer treatment: Targeting simply Ras?
13. Analysis of Ras protein expression in mammalian cells
14. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum
15. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB
16. Elevation of α2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors
17. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic
18. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of Ras gene activation
19. K-
20. ras to the plasma membrane
21. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2
22. v12 proteins to farnesyltransferase inhibitors in Rat1 cells
23. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity
24. Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes
25. Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells
26. Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice
27. Non-Ras targets of farnesyltransferase inhibitors: Focus on Rho
28. RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors
29. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice
30. Metabolic radiolabeling techniques for identification of prenylated and fatty acylated proteins
31. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 X DBA/2) mice is inherited as an incomplete dominant trait: Evidence for multi-locus involvement
32. Cloning and characterization of a mammalian prenyl protein-specific protease
33. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity
34. Endoplasmic reticulum membrane localization of Rce1p and Ste24p, yeast proteases involved in carboxyl-terminal CAAX protein processing and amino-terminal a-factor cleavage
35. Inhibitors of Ras farnesyltransferases
36. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines
37. Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targetting and transformation
38. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors
39. Postisoprenylation protein processing: CXXX (CaaX) endoproteases and isoprenylcysteine carboxyl methyltransferase
40. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization